Atlas Trials

Chimeric Antigen Receptor Macrophages Targeting c-MET for Advanced Stage of Pancreatic Cancer Patients

Clinical trial NCT07553793 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07553793
Sponsor
Peking Union Medical College Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic CancerAdvanced Stage Cancer
Start date
2026-05-01
Primary completion
2028-12-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.